BiotechTube
Home/Pipeline/BC2027

BC2027

Not Specified (Oncology)

Phase 1FDA IND Cleared (2024)

Key Facts

Indication
Not Specified (Oncology)
Phase
Phase 1
Status
FDA IND Cleared (2024)
Company
BioCity Biopharma

About BioCity Biopharma

A clinical-stage biopharma developing novel BIC/FIC therapeutics for oncology and nephrology, with a multi-modality pipeline and global clinical operations.

View full company profile

Therapeutic Areas

OncologyImmunology

Other Not Specified (Oncology) Drugs

DrugCompanyPhase
IMGS-203ImmunoGenesisPre-clinical
XNW28012Evopoint BiosciencesPhase 3
Anti-TM4SF4 AntibodyAlgok BioPreclinical
Oncology 1Actipulse NeurosciencePre-clinical
SynKIR™-310Verismo TherapeuticsPhase 1
AUR112Aurigene OncologyPhase 1
B7H3 Antibody-Drug ConjugateEllipses PharmaClinical
BC3448BioCity BiopharmaPhase 1